| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Analysis of 31 Cases of Primary Breast Lymphoma: The Effect of Nodal Involvement and Microvascular Density
|
Zhao, Shu
|
|
2011
|
11 |
1 |
p. 33-37
5 p.
|
artikel
|
| 2 |
Associated Malignancies in Patients with Waldenström's Macroglobulinemia and Their Kin
|
Hanzis, Christina
|
|
2011
|
11 |
1 |
p. 88-92
5 p.
|
artikel
|
| 3 |
Augmented Hyper-CVAD Based on Dose-Intensified Vincristine, Dexamethasone, and Asparaginase in Adult Acute Lymphoblastic Leukemia Salvage Therapy
|
Faderl, Stefan
|
|
2011
|
11 |
1 |
p. 54-59
6 p.
|
artikel
|
| 4 |
Autologous Stem Cell Transplantation as a Care Option in Waldenström's Macroglobulinemia
|
Usmani, Saad
|
|
2011
|
11 |
1 |
p. 139-142
4 p.
|
artikel
|
| 5 |
Bendamustine Therapy in Patients With Relapsed or Refractory Waldenström's Macroglobulinemia
|
Treon, Steven P.
|
|
2011
|
11 |
1 |
p. 133-135
3 p.
|
artikel
|
| 6 |
Can ISSWM Be Used for Making Treatment Decisions?
|
Morel, Pierre
|
|
2011
|
11 |
1 |
p. 121-123
3 p.
|
artikel
|
| 7 |
CD138 Expression Helps Distinguishing Waldenström's Macroglobulinemia (WM) From Splenic Marginal Zone Lymphoma (SMZL)
|
Kyrtsonis, Marie-Christine
|
|
2011
|
11 |
1 |
p. 99-102
4 p.
|
artikel
|
| 8 |
CD30-Positive EBV–Associated Diffuse Large B-Cell Lymphoma Occurring After Immunosuppressive Therapy for T-Cell Prolymphocytic Leukemia
|
Alduaij, Ahmad
|
|
2011
|
11 |
1 |
p. 64-67
4 p.
|
artikel
|
| 9 |
Copy Number Variations of EphA3 Are Associated With Multiple Types of Hematologic Malignancies
|
Guan, Ming
|
|
2011
|
11 |
1 |
p. 50-53
4 p.
|
artikel
|
| 10 |
Differential Diagnosis of IgM MGUS and WM According to B-Lymphoid Infiltration by Morphology and Flow Cytometry
|
Ocio, Enrique M.
|
|
2011
|
11 |
1 |
p. 93-95
3 p.
|
artikel
|
| 11 |
Distinctive Clinical and Histological Features of Waldenström's Macroglobulinemia and Splenic Marginal Zone Lymphoma
|
Arcaini, Luca
|
|
2011
|
11 |
1 |
p. 103-105
3 p.
|
artikel
|
| 12 |
Effects of Lenalidomide and Dexamethasone Treatment Duration on Survival in Patients With Relapsed or Refractory Multiple Myeloma Treated With Lenalidomide and Dexamethasone
|
San-Miguel, Jesús F.
|
|
2011
|
11 |
1 |
p. 38-43
6 p.
|
artikel
|
| 13 |
Efficacy and Safety of Pegylated Liposomal Doxorubicin in Combination With Bortezomib for Multiple Myeloma: Effects of Adverse Prognostic Factors on Outcome
|
Bladé, Joan
|
|
2011
|
11 |
1 |
p. 44-49
6 p.
|
artikel
|
| 14 |
Expression of CCL3 by Neoplastic Cells in Patients with Waldenström's Macroglobulinemia: An Immunohistochemical Study in Bone Marrow Biopsies of 67 Patients
|
Terpos, Evangelos
|
|
2011
|
11 |
1 |
p. 115-117
3 p.
|
artikel
|
| 15 |
Factors Predicting Transformation of Asymptomatic IgM Monoclonal Gammopathy
|
Greco, Antonino
|
|
2011
|
11 |
1 |
p. 77-79
3 p.
|
artikel
|
| 16 |
Familial Paraproteinemia: Hyper-Responsive B-Cells as Endophenotype
|
Ögmundsdóttir, Helga M.
|
|
2011
|
11 |
1 |
p. 82-84
3 p.
|
artikel
|
| 17 |
Familial Plasma Cell Disorders and Associated Cancers
|
Lynch, Henry T.
|
|
2011
|
11 |
1 |
p. 80-81
2 p.
|
artikel
|
| 18 |
Hepcidin Is Produced by Lymphoplasmacytic Cells and Is Associated With Anemia in Waldenström's Macroglobulinemia
|
Ciccarelli, Bryan T.
|
|
2011
|
11 |
1 |
p. 160-163
4 p.
|
artikel
|
| 19 |
Heterogeneity of Histological Transformation Events in Waldenström's Macroglobulinemia (WM) and Related Disorders
|
Owen, R G
|
|
2011
|
11 |
1 |
p. 176-179
4 p.
|
artikel
|
| 20 |
High-Throughput Genomic Analysis in Waldenström's Macroglobulinemia
|
Poulain, Stéphanie
|
|
2011
|
11 |
1 |
p. 106-108
3 p.
|
artikel
|
| 21 |
Histone Deacetylase Inhibitors Demonstrate Significant Preclinical Activity as Single Agents, and in Combination with Bortezomib in Waldenström's Macroglobulinemia
|
Sun, Jenny Y.
|
|
2011
|
11 |
1 |
p. 152-156
5 p.
|
artikel
|
| 22 |
IgM Amyloidosis: Clinical Features in Therapeutic Outcomes
|
Gertz, Morie A.
|
|
2011
|
11 |
1 |
p. 146-148
3 p.
|
artikel
|
| 23 |
IgM Monoclonal Gammopathy of Undetermined Significance (MGUS) and Smoldering Waldenström's Macroglobulinemia (SWM)
|
Kyle, Robert A.
|
|
2011
|
11 |
1 |
p. 74-76
3 p.
|
artikel
|
| 24 |
Immunohistochemical Phenotyping of Plasma Cells in Lymphoplasmacytic Lymphoma/Waldenström's Macroglobulinemia is Comparable to Flow Cytometric Techniques
|
Howard, Matthew T.
|
|
2011
|
11 |
1 |
p. 96-98
3 p.
|
artikel
|
| 25 |
Jak/Stat Pathway in Waldenström's Macroglobulinemia
|
Hodge, Lucy S.
|
|
2011
|
11 |
1 |
p. 112-114
3 p.
|
artikel
|
| 26 |
Key Role of MicroRNAs in Waldenström's Macroglobulinemia Pathogenesis
|
Sacco, Antonio
|
|
2011
|
11 |
1 |
p. 109-111
3 p.
|
artikel
|
| 27 |
Large Vessel (Takayasu's) Arteritis in a Patient With Myelodysplastic Syndrome: Is There a Common Pathogenesis?
|
Cohen, Matan J.
|
|
2011
|
11 |
1 |
p. 60-63
4 p.
|
artikel
|
| 28 |
Matrix Metalloproteinase-8 Is Overexpressed in Waldenström's Macroglobulinemia Cells, and Specific Inhibition of this Metalloproteinase Blocks Release of Soluble CD27
|
Zhou, Yangsheng
|
|
2011
|
11 |
1 |
p. 172-175
4 p.
|
artikel
|
| 29 |
Novel Diagnostic Approaches in Bing-Neel Syndrome
|
Ly, K. Ina
|
|
2011
|
11 |
1 |
p. 180-183
4 p.
|
artikel
|
| 30 |
Novel M-Component Based Biomarkers in Waldenström's Macroglobulinemia
|
Leleu, Xavier
|
|
2011
|
11 |
1 |
p. 164-167
4 p.
|
artikel
|
| 31 |
Pathogenesis and Morbidity of Autoantibody Syndromes in Waldenstrom's Macroglobulinemia
|
Stone, Marvin J.
|
|
2011
|
11 |
1 |
p. 157-159
3 p.
|
artikel
|
| 32 |
Phase I Study of Atacicept in Relapsed/Refractory Multiple Myeloma (MM) and Waldenström's Macroglobulinemia
|
Rossi, Jean-François
|
|
2011
|
11 |
1 |
p. 136-138
3 p.
|
artikel
|
| 33 |
Post-Treatment Bone Marrow Residual Disease > 5% by Flow Cytometry Is Highly Predictive of Short Progression-Free and Overall Survival in Patients With Waldenström's Macroglobulinemia
|
García-Sanz, R
|
|
2011
|
11 |
1 |
p. 168-171
4 p.
|
artikel
|
| 34 |
Prognostication of the High-Risk WM Patient
|
Kastritis, Efstathios
|
|
2011
|
11 |
1 |
p. 127-129
3 p.
|
artikel
|
| 35 |
Prognostic Relevance of Immunohistochemical Subclassification of Diffuse Large B-Cell Lymphoma in Two Prospective Phase III Clinical Trials
|
Rayman, Nazik
|
|
2011
|
11 |
1 |
p. 23-32
10 p.
|
artikel
|
| 36 |
Report From the Sixth International Workshop on Waldenström's Macroglobulinemia
|
Treon, Steven P.
|
|
2011
|
11 |
1 |
p. 69-73
5 p.
|
artikel
|
| 37 |
Rituximab and Subcutaneous 2-Chloro-2′-Deoxyadenosine as Therapy in Untreated and Relapsed Waldenström's Macroglobulinemia
|
Laszlo, D
|
|
2011
|
11 |
1 |
p. 130-132
3 p.
|
artikel
|
| 38 |
Tanespimycin as Antitumor Therapy
|
Dimopoulos, Meletios-Athanassios
|
|
2011
|
11 |
1 |
p. 17-22
6 p.
|
artikel
|
| 39 |
The Bone Marrow Niche in Waldenström's Macroglobulinemia
|
Ghobrial, Irene M.
|
|
2011
|
11 |
1 |
p. 118-120
3 p.
|
artikel
|
| 40 |
The Impact of Advanced Age According to IPSSWM Cut-Off on the Outcome of Symptomatic and Asymptomatic Waldenström's Macroglobulinemia at Diagnosis
|
Ricci, F
|
|
2011
|
11 |
1 |
p. 124-126
3 p.
|
artikel
|
| 41 |
Treatment of IgM-Associated AL Amyloidosis With the Combination of Rituximab, Bortezomib, and Dexamethasone
|
Palladini, Giovanni
|
|
2011
|
11 |
1 |
p. 143-145
3 p.
|
artikel
|
| 42 |
Treatment of Unfit Patients With Acute Myeloid Leukemia: A Still Open Clinical Challenge
|
Ferrara, Felicetto
|
|
2011
|
11 |
1 |
p. 10-16
7 p.
|
artikel
|
| 43 |
Update in Indolent Non-Hodgkin Lymphoma (NHL): Paradigm for Waldenström's Macroglobulinemia (WM)
|
Chiappella, Annalisa
|
|
2011
|
11 |
1 |
p. 149-151
3 p.
|
artikel
|
| 44 |
What Causes Waldenström's Macroglobulinemia: Genetic or Immune-Related Factors, or a Combination?
|
Kristinsson, Sigurdur Y.
|
|
2011
|
11 |
1 |
p. 85-87
3 p.
|
artikel
|
Tijdschrift beschrijving